Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nucleotides are small organic molecules composed of three components: a nitrogenous base (purine—adenine [A], guanine [G]; pyrimidine—cytosine [C], thymine [T], uracil [U]), a five-carbon sugar (ribose in RNA; deoxyribose in DNA), and one or more phosphate groups. They serve primarily as the monomeric building blocks for nucleic acids—DNA and RNA—which store genetic information essential for life. Beyond this structural role, certain free nucleotides function critically in cellular energy transfer—as exemplified by adenosine triphosphate (ATP)—and participate directly in cell signaling pathways through cyclic forms like cAMP and cGMP. Nucleotides also play key roles during protein synthesis via tRNA/mRNA/rRNA interactions. While vital for all living systems, “nucleotide” is not considered a therapeutic target itself but rather an essential metabolite whose analogues form the basis of several classes of antiviral and anticancer drugs.
Drugs that interact with nucleotide pathways typically act by mimicking natural nucleotides to inhibit viral replication or disrupt DNA synthesis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nucleotide.